KL and lung carcinoma: In vivo efficacy analysis using a xenograft mouse model of human lung carcinoma indicated that injection of TCTP-KLA into xenografts established in nude mice regresses the tumor growth more efficiently than that of TAT-KLA (Kim et al., 2011a).